Filing Flows › Sanofi (SNY) › Q3 2026 › vs Q3 2025
Sanofi (SNY) Q3 2026 vs Q3 2025 (year over year)
Sanofi's revenue rose $2.0B (+16%) from $12.4B in Q3 2025 to $14.4B in Q3 2026. Gross margin 80.3% against 78.5% (+1.8 pts).
Sanofi, Q3 2026: revenue $14.4B (+16% year over year), operating margin 30.1%, net earnings $3.0B. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 80.3% | 78.5% | +1.8 pts |
| Operating margin | 30.1% | 29.1% | +1.0 pts |
| Net margin | 21.0% | 22.6% | -1.6 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $14.4B | $12.4B | $2.0B | +16% |
| Gross profit | $11.6B | $9.8B | $1.8B | +19% |
| Cost of revenue | $2.8B | $2.7B | $167M | +6% |
| Operating profit | $4.3B | $3.6B | $726M | +20% |
| Operating expenses | $7.3B | $6.1B | $1.1B | +18% |
| Pre-tax earnings | $1.8B | $2.1B | −$294M | -14% |
| Other expense, net | $2.5B | $1.5B | $1.0B | +68% |
| Research & development | $1.8B | $1.8B | $15.0M | +0.8% |
| Other operating costs | $5.4B | $4.3B | $1.1B | +26% |
| Income tax benefit | $1.2B | $680M | $515M | +76% |
| Net earnings | $3.0B | $2.8B | $221M | +8% |
Questions
How much did Sanofi's revenue grow year over year in Q3 2026?
Sanofi's revenue rose $2.0B (+16%) from $12.4B in Q3 2025 to $14.4B in Q3 2026. Gross margin 80.3% against 78.5% (+1.8 pts).